These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20506834)

  • 1. [Study of molecular mechanism of anti-Parkinson's disease traditional Chinese medicine using model of Caenorhabditis elegans].
    Wang X; Wang X; Gao H; Wang D
    Zhongguo Zhong Yao Za Zhi; 2010 Mar; 35(5):661-3. PubMed ID: 20506834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
    Nass R; Merchant KM; Ryan T
    Mol Interv; 2008 Dec; 8(6):284-93. PubMed ID: 19144901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
    Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
    Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caenorhabditis elegans as a model system for Parkinson's disease.
    Schmidt E; Seifert M; Baumeister R
    Neurodegener Dis; 2007; 4(2-3):199-217. PubMed ID: 17596715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.
    Harrington AJ; Hamamichi S; Caldwell GA; Caldwell KA
    Dev Dyn; 2010 May; 239(5):1282-95. PubMed ID: 20108318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Locke CJ; Fox SA; Caldwell GA; Caldwell KA
    Neurosci Lett; 2008 Jul; 439(2):129-33. PubMed ID: 18514411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
    Fumagalli F; Racagni G; Riva MA
    Pharmacogenomics J; 2006; 6(2):95-104. PubMed ID: 16402079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of traditional Chinese medicine on animal model of Parkinson's disease].
    Wu B; Zhao S; Wang X; Dong Q; Zheng G
    Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2588-91. PubMed ID: 22256772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
    Ekstrand MI; Galter D
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S185-8. PubMed ID: 20082987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease: insights from non-traditional model organisms.
    Pienaar IS; Götz J; Feany MB
    Prog Neurobiol; 2010 Dec; 92(4):558-71. PubMed ID: 20851733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Drosophila model of Parkinson's disease.
    Feany MB; Bender WW
    Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
    Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
    Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advance in studies on pathological mechanism of Parkinson's disease and traditional Chinese medicine experiments in prevention and treatment of Parkinson's disease].
    Xiong P; Chen X; Zhang N
    Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):686-91. PubMed ID: 22693916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
    Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A
    Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M; Lopiano L
    Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.